相关实验视频
Updated: Jun 24, 2025

Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
为新型长效注射抗精神病药物RISPERIDONE ISM®开发一个人群药动力学模型
Christian Laveille1, Eric Snoeck2, Lourdes Ochoa Díaz de Monasterioguren3
1Calvagone SAS, Liergues, France.
这项研究开发了RISPERIDONE ISM®的种群药动力学模型,以了解身体质量指数和性别如何影响药物暴露. 该模型证实RISPERIDONE ISM®在每月注射后迅速达到并保持治疗水平.
科学领域:
- 药理动力学 药理动力学
- 药物指标 (Pharmacometrics) 是一个指标.
- 精神分裂症治疗 治疗精神分裂症
背景情况:
- 里斯比里长效注射配方旨在改善精神分裂症患者的治疗坚持和治疗结果.
- 了解这些配方的药理动力学变异性对于优化剂量策略至关重要.
研究的目的:
- 开发一个人群药理动力学 (PK) 模型,用于RISPERIDONE ISM®.
- 为了确定影响活性部分暴露的共变量,特别是明显清除 (CL40).
主要方法:
- 使用NONMEM软件进行人口PK建模.
- 结合了来自五项临床研究的数据,包括健康志愿者和精神分裂症患者.
- 共变量分析侧重于CL40,BMI和性别被确定为重要因素.
主要成果:
- 一个具有复杂吸收和第一阶淘汰的单间模型充分描述了数据.
- 影响CL40的重要共变量被确定为身体质量指数 (BMI) 和性别.
- 视觉预测检查证实了模型与观察到的数据的良好匹配.
结论:
- 开发的群体PK模型准确地代表了在不同患者群体中RISPERIDONE ISM®的药理动力学.
- 该模型为未来研究的模拟提供了便利,并有助于理解暴露-共变量关系.
- 里斯佩里ISM®在每月进行部注射后,可以达到快速和持续的治疗性血水平.
相关概念视频
Analysis of Population Pharmacokinetic Data
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

